AMLX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 120996 min ago

@ $15.05

Wydano: 14 vas. 2024 @ 22:52

Zwrot: -87.18%

Poprzedni sygnał: vas. 14 - 22:25

Poprzedni sygnał: Sprzedaż

Zwrot: -0.69 %

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 23:00):

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases...

Stats
Dzisiejszy wolumen	1.49M
Średni wolumen	3.51M
Kapitalizacja rynkowa	131.25M
EPS	$0 ( 2024-02-22 )
Następna data zysków	( $0.240 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	2.76
ATR14	$0.00500 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Frates James M	Buy	91 180	Common Stock
2024-04-16	Frates James M	Buy	120 000	Stock Option (right to buy)
2024-04-16	Cohen Joshua B	Buy	179 850	Common Stock
2024-04-16	Cohen Joshua B	Buy	380 000	Stock Option (right to buy)
2024-04-16	Mazzariello Gina	Buy	80 560	Common Stock

INSIDER POWER
25.53
Last 97 transactions
Buy: 3 771 999 \| Sell: 3 035 438

Wolumen Korelacja

Długi: -0.33 (neutral)

Krótki: -0.55 (weak negative)

Signal:(59.998) Neutral

Amplify YieldShares Oil Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amplify YieldShares Oil Korelacja - Waluta/Towar

0.41
( neutral )

0.50
( neutral )

0.00
( neutral )

Amplify YieldShares Oil Finanse

Annual	2023
Przychody:	$380.79M
Zysk brutto:	$355.35M (93.32 %)
EPS:	$0.730

FY	2023
Przychody:	$380.79M
Zysk brutto:	$355.35M (93.32 %)
EPS:	$0.730

FY	2022
Przychody:	$22.23M
Zysk brutto:	$19.24M (86.54 %)
EPS:	$-2.98

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.592

Financial Reports:

No articles found.

Amplify YieldShares Oil

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Aktualne aktualizacje dla Amplify YieldShares Oil [AMLX]

Upcoming Earnings Alert